Close
Written By: Jeffrey Atlas, PA-C, Health Content Writer
Medically Reviewed By: Dr. Gopal Grandhige, MD, FACS, Board-Certified Surgeon
Last Reviewed: March 1, 2026
On February 27, 2026, HHS Secretary Robert F. Kennedy Jr. announced that approximately 14 of the 19 peptides placed on the FDA’s Category 2 restricted list in 2023 will return to Category 1 status. This reclassification allows licensed compounding pharmacies to legally prepare these peptides again when prescribed by a physician.
The peptides expected to return include BPC-157 for tissue repair, Thymosin Alpha-1 for immune support, AOD-9604 for metabolic health, GHK-Cu for anti-aging, and several others used for recovery, cognitive function, and hormonal balance.
These peptides still do not carry FDA approval and will require a prescription from a licensed medical provider. Over-the-counter availability is not anticipated. Grey-market peptides sold as “research use only” remain unregulated and pose significant safety risks.
As of this writing, the FDA has not published its official updated list. Patients interested in peptide therapy should work with qualified healthcare providers and source peptides only from licensed compounding pharmacies once they become legally available.
If you’ve been keeping up with peptides, you know the past few years have been rocky. Peptides that millions of people depended on for gut health, recovery, immune support, and metabolic optimization were abruptly removed from compounding pharmacy shelves in late 2023. Clinicians lost access to tools they had used safely for years. Patients were left searching for alternatives, with many turning to unregulated “research” suppliers that offered no quality assurances.
That’s about to change.
On February 27, 2026, HHS Secretary Robert F. Kennedy Jr. announced on the Joe Rogan Experience that roughly 14 of the 19 peptides currently banned under the FDA’s Category 2 list will be reclassified to Category 1. This means compounding pharmacies can legally prepare them again under physician prescription.
Here’s what you need to know.
The official FDA list has not been released yet, but regulatory experts and industry analysts have identified the peptides most likely to return to legal compounding status. Based on the strength of existing safety data and the nature of each compound, the following are expected to shift back to Category 1:
This is arguably the most recognized and sought-after peptide today. BPC-157 is derived from a fragment of a naturally occurring protein found in gastric juice. Researchers have studied it extensively for its role in gut healing, tendon repair, musculoskeletal recovery, and inflammation reduction. Human clinical trials remain limited, but animal research is robust, and clinical feedback from practitioners has been overwhelmingly positive.
Connection to metabolic health: Gut barrier function is now understood as a critical factor in metabolic syndrome, insulin resistance, and systemic inflammation.
This is a naturally occurring peptide that supports tissue repair, wound healing, and inflammation control. Studies have examined its potential for cardiac tissue repair, corneal healing, and musculoskeletal recovery.
This stands as one of the most well-documented peptides on the list. Thymosin Alpha-1 is approved as a pharmaceutical in over 30 countries for hepatitis B, hepatitis C, and as an immune booster in cancer treatment. Its placement on the Category 2 list drew significant criticism given its established global safety record.
A tripeptide fragment of alpha-MSH that carries strong anti-inflammatory properties. Research shows promise for inflammatory bowel conditions and broader immune regulation.
This modified fragment of human growth hormone specifically targets fat metabolism without triggering the broader hormonal effects of full HGH. Originally developed as an anti-obesity treatment, it carries a solid safety profile from Phase II clinical trials and even received GRAS (Generally Recognized as Safe) status from the FDA for use in food products. This made its Category 2 classification particularly confusing to many in the field.
Connection to metabolic health: AOD-9604 operates through a different pathway than GLP-1 receptor agonists. Some practitioners are now looking at whether the two could work together for comprehensive metabolic support, similar to how liposuction can complement medical weight management for body contouring goals.
A mitochondrial-derived peptide that plays a role in metabolic regulation. Researchers have studied it for effects on insulin sensitivity, glucose metabolism, and as a potential exercise mimetic, meaning it may activate some of the same metabolic pathways triggered by physical activity.
Connection to metabolic health: MOTS-C is one of the most promising peptides for anyone focused on metabolic optimization. It works at the mitochondrial level to improve how your body processes energy.
A naturally occurring tripeptide that decreases with age. It has been studied extensively for skin rejuvenation and wound healing, with emerging evidence pointing to broader systemic anti-aging benefits including anti-inflammatory and antioxidant effects.
A synthetic version of the naturally occurring peptide epithalamin, which the pineal gland produces. Researchers have studied it for its effects on telomerase activation and telomere length, both key markers in the biology of aging.
A synthetic peptide based on a fragment of ACTH (adrenocorticotropic hormone). It holds approval in Russia as a prescription medication for cognitive enhancement and stroke recovery. It carries neuroprotective and nootropic properties.
An anxiolytic peptide with immune-modulating properties. Like Semax, it holds approval in Russia as a prescription medication. Studies have examined it for anxiety, cognitive function, and immune support.
A neuropeptide that plays a central role in regulating reproductive hormones. Active clinical trials are studying it for conditions including hypogonadism, infertility, and hormonal imbalance.
Connection to metabolic health: Hormonal balance, particularly testosterone and estrogen levels, directly impacts metabolic function, body composition, and energy regulation.
A neuropeptide linked to sleep regulation. Poor sleep remains one of the most overlooked contributors to metabolic dysfunction, insulin resistance, and weight gain.
In late 2023, the FDA reclassified 19 popular peptides as “Category 2” bulk drug substances. This designation is reserved for compounds the agency believes carry significant safety risks. The decision effectively blocked compounding pharmacies from preparing these peptides for patients.
The 19 peptides placed on the restricted list included:
The FDA justified the crackdown by citing concerns over immunogenicity (immune reactions), manufacturing impurities, and the absence of large-scale human clinical trials.
However, critics pushed back hard. Clinicians, compounding pharmacists, and even members of Congress argued the move was regulatory overreach. Their concern? The ban would drive patients toward unregulated gray-market sources, creating the exact safety issues the FDA claimed it wanted to prevent.
Kennedy announced that the FDA’s original Category 2 classifications lacked legitimate safety concerns. As a result, roughly 14 of the 19 peptides will return to Category 1 status within weeks of the announcement.
Category 1 status means:
What it does NOT mean:
Understanding this distinction is essential for anyone considering peptide therapy.
These are substances that compounding pharmacies can use while the FDA continues its evaluation process. If a peptide lands on the Category 1 list, it remains eligible for compounding under Sections 503A and 503B, provided all other regulatory requirements are met.
Substances placed in Category 2 have been flagged for potential safety concerns. Peptides on this list are generally not permitted for compounding use.
Important to Know:
Compounded medications are not the same as FDA-approved drugs. They are customized preparations created by licensed pharmacies to address specific patient needs. At Formation in Tampa, Dr. Gopal Grandhige works only with reputable compounding pharmacies that follow strict quality and safety standards when peptide therapy is part of a patient’s treatment plan.
Around five of the 19 peptides are expected to remain on the Category 2 list due to more serious safety concerns or limited human evidence. These likely include:
Keep in mind that these classifications are speculative until the FDA formally publishes its updated list. At Formation in Tampa, Dr. Gopal Grandhige stays current on all regulatory changes to ensure patients receive only safe, evidence-backed peptide therapies.
This matters: once these peptides return to legal compounding status, there’s no reason to continue taking risks with “research use only” products. Grey-market peptides come with zero quality guarantees. Independent testing has repeatedly uncovered incorrect dosing, contamination, and even completely wrong compounds in vials purchased from unregulated suppliers.
When legal compounding returns, you’ll have access to pharmaceutical-grade peptides from licensed, inspected pharmacies with proper certificates of analysis, all prepared under a physician’s guidance.
The return of legal compounding means you can have a real conversation with your doctor about whether peptide therapy makes sense for you. This is especially relevant if you’re focused on:
For those also interested in men’s aesthetic surgery, peptide therapy may support recovery and overall wellness goals alongside treatments like PDO thread lifts, Botox, or HD lipo.
At Formation, peptide therapy and PRP hair restoration treatments are administered by Jeff Atlas, PA-C, a physician assistant with a background in orthopedics who brings hands-on expertise in musculoskeletal health, regenerative techniques, and injection precision to every session. Under the medical direction of Dr. Gopal Grandhige, Jeff works closely with each patient to tailor protocols that support recovery, performance, and long-term wellness. His orthopedic training gives him a distinct advantage when it comes to understanding how the body heals, making him an ideal fit for patients seeking results grounded in clinical experience rather than guesswork.
In most cases, the answer is no.
Compounded peptides are typically cash-pay treatments. They’re considered off-label and are not reimbursed by insurance providers.
A balanced perspective matters here.
Potential risks include immune reactions, injection site reactions, and hormonal disruption, particularly with growth hormone-related peptides. There’s also the risk of contamination if peptides are sourced improperly, along with dosing variability between products.
Another consideration is that long-term safety data remains limited. Most peptides have not undergone large-scale, long-duration randomized controlled trials.
For these reasons, patients should only use peptide therapy under proper medical supervision. At Formation, Dr. Gopal Grandhige ensures all peptide treatments are administered safely and sourced from reputable compounding pharmacies. To see examples of our approach to patient care and results, visit our patient gallery.
Whether you’re considering peptide therapy or procedures like jawline contouring, injectable treatments, or male tummy tuck, working with a Tampa plastic surgeon ensures you receive personalized guidance based on your unique goals.
The peptide landscape is changing faster than it has in over a decade. The anticipated return of 14 peptides to legal compounding status marks a major victory for patients and practitioners who have pushed for evidence-based access to these compounds through safe, regulated channels.
However, this distinction matters: “legal to compound” does not mean “proven safe and effective for everyone.” Peptides should be prescribed by a qualified healthcare provider, sourced from licensed compounding pharmacies, and used as part of a medically supervised program.
With Jeff Atlas, PA-C leading your treatment and Dr. Gopal Grandhige providing medical oversight, every peptide therapy and PRP hair restoration session at Formation is built on clinical precision and real-world experience. Jeff’s orthopedic background means your care is guided by someone who understands how the body responds, recovers, and rebuilds from the inside out.
Ready to learn more? Schedule a consultation to discuss your options.
We’ll be publishing detailed breakdowns of each of these peptides in the coming weeks. Subscribe to stay informed.
Several peptides may become eligible for compounding once they receive Category 1 reclassification. Official FDA publication is still pending, so availability timelines remain uncertain.
The legal status of BPC-157 hinges on upcoming FDA classification updates. Currently, it does not hold FDA approval for therapeutic use.
The majority of peptides are not FDA-approved drugs in the United States. Their regulatory status varies depending on intended use and source.
Pharmacies can begin offering these peptides after the FDA formally reclassifies them and facilities complete the necessary compliance verification processes.
Peptides and GLP-1 medications work through different biological mechanisms. Rather than serving as direct replacements, certain peptides may function as complementary options depending on individual health goals. Dr. Gopal Grandhige can help determine which approach aligns best with your needs during a consultation at Formation in Tampa.
Let’s talk filler placements! 👀
From standard touch-ups to total profile balancing, dermal filler is incredibly versatile. Check out the reel to see all the areas we can treat to enhance your natural beauty.
The secret to great filler? A customized plan. 🎨
👇 Take the next step:
DM us “CONSULT” or click the link in our bio to book your one-on-one consultation today. Let’s see what filler can do for you!
The power of a profile transformation. 🔥
For this patient, we combined PDO Lifting Threads and advanced chin/jawline filler to completely redefine his lower face. By strategically lifting the mid-to-lower face and sculpting the jaw, we didn’t just enhance one feature—we elevated his entire facial appearance.
An incredible, natural-looking result that brings balance and confidence from every angle.
Note: Minor bunching or puckering is completely normal immediately following a PDO thread lift. The slight bunching visible in the after photo will fully subside on its own over the next 2-4 weeks as the threads settle.
#JawlineContouring #PDOThreads #FacialSculpting #JawlineFiller #mensaesthetics
Last week, we partnered with @epicutis for an exclusive evening of luxury, connection, and next-level skin. From complimentary skin analysis scans to good company and great vibes — this is what elevated beauty looks like. Thank you to everyone who joined us. 🥂
#Epicutis #Tampa
#LuxurySkicare #Emage #skingoals
Check out this incredible before and after of our gorgeous patient 6 months following her Female HD Liposculpture! ⏳
While these results are already stunning, here is a little insider secret: she’s not even at her final result yet! Healing from high-definition liposculpture is a journey. Over the next few months, residual swelling will continue to subside, and any temporary skin texture changes or minor discoloration will fully resolve. As the tissues settle, her skin will keep tightening to reveal even more crisp, beautifully defined athletic contours.
We love seeing our patients blossom through their recovery. Patience pays off, and her body will only continue to lean out and lock in over the coming months!
What do you think of her 6-month transformation? Drop a 👇 in the comments!
#BodyContouring #HDLipo #SkinTightening #PostOpHealing
PRP (Platelet-Rich Plasma) scalp injections use your own growth factors to reawaken dormant follicles, thicken existing strands, and naturally stimulate regrowth — no surgery, no downtime.
If you’ve been watching your part widen or your ponytail thin, this is your sign. 👇
📍Formation | Tampa
📞 Book your free consultation via the link in bio.
#PRPHairTreatment #HairRestoration #PRPScalpInjections #HairLossSolution #HairGrowth
Did you know that you can snatch your jaw with Botox?
Use the link in our bio to schedule a consultation so we can discuss all of the ways injectables can benefit YOU
#nefertitilift #botox #tampa
This patient’s transformation showcases the power of combining procedures:
High-Definition Liposculpture + Renuvion® skin tightening with fat transfer to the chest.
HD Lipo goes beyond traditional liposuction to sculpt and define the underlying muscle anatomy, while Renuvion uses helium plasma energy to tighten the skin from the inside out. The fat transfer to the chest adds natural volume and projection for a truly athletic contour.
The work is done. The confidence is his. 💪
📍 Formation Tampa
📲 Book your consultation via the link in bio.
#HDLipo #HighDefinitionLiposuction #Renuvion #BodySculpting #FatTransfer MaleBodyContouring
Six months post extended abdominoplasty, and we are loving these seamless, natural results. By focusing on feminine contours and a refined waistline, we achieved a silhouette that looks as good as it feels.
Proof that surgery can—and should—look effortless.
#NaturalResults #Abdominoplasty #BodyTransformation #Tampa #tummytuck
Lift, tighten, and refresh — without going under the knife. ✨ PDO thread lifts are one of the most effective non-surgical treatments for restoring structure to the face. They stimulate collagen production, improve skin texture, and deliver natural-looking results that keep getting better over time. Ready to turn back the clock? Drop your questions below 👇
#PDOThreads #ThreadLift #NonSurgicalLift #CollagenBoost #antiaging
A journey that began with dedication, completed with precision. ✨
This patient worked tirelessly to lose weight, only to be left with the final hurdle: skin laxity that diet and exercise couldn`t touch. A circumferential lift was performed to remove the excess tissue "belt" around the entire midsection.
Today, at 12 months post-op, the transformation is complete. It’s not just about a flatter silhouette; it’s about a body that finally matches the strength and hard work they put in. The confidence? Unstoppable. 🏔️
#BodyLift #PostWeightLoss #CircumferentialLift #SkinRemoval #BodyContouring #OneYearPostOp #TransformationTuesday #MyJourney #TampaBay
References:
Centers for Disease Control and Prevention. (2024). Insulin resistance and diabetes. U.S. Department of Health and Human Services. https://www.cdc.gov/diabetes/about/insulin-resistance-and-diabetes.html
Cleveland Clinic. (2022). Low testosterone (male hypogonadism). https://my.clevelandclinic.org/health/diseases/15216-low-testosterone-male-hypogonadism
Dominari, A., Hathaway, D., III, Pandav, K., Matos, W., Biswas, S., Reddy, G., Thevuthasan, S., Khan, M. A., Mathew, A., Makkar, S. S., Zaidi, M., Fahem, M. M. M., Beas, R., Castaneda, V., Paul, T., Halpern, J., & Baralt, D. (2020). Thymosin alpha 1: A comprehensive review of the literature. World Journal of Virology, 9(5), 67–78. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271064/
Lipton, J. M., & Catania, A. (1997). Anti-inflammatory actions of the neuroimmunomodulator α-MSH. Immunology Today, 18(3), 140–145. https://pubmed.ncbi.nlm.nih.gov/16098474/
National Heart, Lung, and Blood Institute. (2022). Metabolic syndrome. National Institutes of Health. https://www.nhlbi.nih.gov/health/metabolic-syndrome
Nature Education. (n.d.). Telomerase. Scitable by Nature Education. https://www.nature.com/scitable/definition/telomerase-90/
Sikirica, M. V., Martin, A. A., Wood, R., Engel, S. S., & Sheer, R. L. (2017). Pre-filled syringe delivery of GLP-1 receptor agonist therapy: A focus on patient-reported outcomes. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK551568/
U.S. Food and Drug Administration. (2023). Compounding laws and policies. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
U.S. Food and Drug Administration. (2024). Generally recognized as safe (GRAS). https://www.fda.gov/food/food-ingredients-packaging/generally-recognized-safe-gras
U.S. Food and Drug Administration. (2024). Human drug compounding overview. https://www.fda.gov/drugs/human-drug-compounding/human-drug-compounding-overview
Wang, X., Sanborn, M., Bhardwaj, A., & Bhardwaj, N. (2014). Immunogenicity assessment in biotherapeutic drug development. Clinical Immunology, 152(1–2), 43–54. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054822/
Peptides optimize the effort you are putting in. Get a FREE 15-minute Virtual Protocol Review + our Regenerative Treatment Newsletter.
We’ll show you exactly how we evaluate candidacy — plus, we cover the cost of your baseline labs with all in-person consults ($100).
